1. Home
  2. GUT vs VERV Comparison

GUT vs VERV Comparison

Compare GUT & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GUT
  • VERV
  • Stock Information
  • Founded
  • GUT 1999
  • VERV 2018
  • Country
  • GUT United States
  • VERV United States
  • Employees
  • GUT N/A
  • VERV N/A
  • Industry
  • GUT Trusts Except Educational Religious and Charitable
  • VERV Medicinal Chemicals and Botanical Products
  • Sector
  • GUT Finance
  • VERV Health Care
  • Exchange
  • GUT Nasdaq
  • VERV Nasdaq
  • Market Cap
  • GUT 398.9M
  • VERV 382.5M
  • IPO Year
  • GUT N/A
  • VERV 2021
  • Fundamental
  • Price
  • GUT $5.30
  • VERV $4.85
  • Analyst Decision
  • GUT
  • VERV Strong Buy
  • Analyst Count
  • GUT 0
  • VERV 4
  • Target Price
  • GUT N/A
  • VERV $25.75
  • AVG Volume (30 Days)
  • GUT 176.3K
  • VERV 1.6M
  • Earning Date
  • GUT 01-01-0001
  • VERV 11-05-2024
  • Dividend Yield
  • GUT 10.93%
  • VERV N/A
  • EPS Growth
  • GUT N/A
  • VERV N/A
  • EPS
  • GUT N/A
  • VERV N/A
  • Revenue
  • GUT N/A
  • VERV $24,396,000.00
  • Revenue This Year
  • GUT N/A
  • VERV $84.66
  • Revenue Next Year
  • GUT N/A
  • VERV N/A
  • P/E Ratio
  • GUT N/A
  • VERV N/A
  • Revenue Growth
  • GUT N/A
  • VERV 219.91
  • 52 Week Low
  • GUT $4.60
  • VERV $4.31
  • 52 Week High
  • GUT $7.38
  • VERV $19.34
  • Technical
  • Relative Strength Index (RSI)
  • GUT 59.26
  • VERV 40.26
  • Support Level
  • GUT $4.97
  • VERV $4.44
  • Resistance Level
  • GUT $5.40
  • VERV $4.93
  • Average True Range (ATR)
  • GUT 0.09
  • VERV 0.48
  • MACD
  • GUT 0.04
  • VERV -0.18
  • Stochastic Oscillator
  • GUT 76.74
  • VERV 17.30

About GUT Gabelli Utility Trust (The)

Gabelli Utility Trust operates as a diversified closed-end investment management company. The fund's primary objective is the long-term growth of capital and income. To achieve its objective, the fund may invest its assets in common stocks and other securities of foreign and domestic companies involved in providing products, services, or equipment for the generation or distribution of electricity, gas, & water; and telecommunications services or infrastructure operations. It invests in various sectors, of which Electric Integrated, Water, Telecommunications, and U.S. Government Obligations and others.

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: